During a recent episode of her podcast, Gwyneth Paltrow spoke with neuroscientist Dr
Retatrutide represents an example of this next generation of metabolic therapies
Miura M, Igarashi M, Isotani R, Nakagawa-Nagahama Y, Kuranami S, Naruse K, et al
Pre-existing nutrient deficiencies If you entered tirzepatide treatment with low iron, low ferritin, low vitamin D, or low zinc, you face compounded risk
Serious side effects appear to be rare in current data
At todays ~14 forward earnings (and a reverse DCF that still requires 1315 % perpetual FCF growth for a 10 % return), Novo Nordisk offers almost no forgiveness for the many things that can still go wrong